Guest guest Posted September 29, 2004 Report Share Posted September 29, 2004 Proposal Aimed at Reducing Mad Cow Risk FDA Proposal Aimed at Reducing Risk of Mad-Cow Tainted Components in Human, Animal Drugs The Associated Press WASHINGTON Sept. 22, 2004 — The government is taking steps to reduce the already minimal risk of mad-cow tainted components ending up in childhood vaccines and other medications. Pharmaceuticals regulated by the Food and Drug Administration, including human vaccines and animal drugs used on farms, routinely use cow products in their manufacture. The agency this summer strengthened safety measures to reduce the chance of mad cow-tainted cow parts winding up in such consumer goods as lipstick and hairspray. One drug company, GlaxoKline, already found alternate sources of materials it uses to produce such products as hepatitis A vaccine and recombinant hepatitis A and B vaccine. While le Halstrom, a GlaxoKline spokeswoman, won't identify the source countries, she said they do not include the United States or Canada. " The entire process was completed more than a year ago ... to ensure we only use materials from countries " with no mad cow infections, Halstrom said. Cow remnants left over from slaughter have long been used to manufacture drugs like vaccines. Serum is drawn from cow's blood and sugars from cow's milk. Amino acids from cow bones are added to growth media to coax along viral vaccines grown in living cells. http://abcnews.go.com/wire/Living/ap20040922_929.html Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 29, 2004 Report Share Posted September 29, 2004 Proposal Aimed at Reducing Mad Cow Risk FDA Proposal Aimed at Reducing Risk of Mad-Cow Tainted Components in Human, Animal Drugs The Associated Press WASHINGTON Sept. 22, 2004 — The government is taking steps to reduce the already minimal risk of mad-cow tainted components ending up in childhood vaccines and other medications. Pharmaceuticals regulated by the Food and Drug Administration, including human vaccines and animal drugs used on farms, routinely use cow products in their manufacture. The agency this summer strengthened safety measures to reduce the chance of mad cow-tainted cow parts winding up in such consumer goods as lipstick and hairspray. One drug company, GlaxoKline, already found alternate sources of materials it uses to produce such products as hepatitis A vaccine and recombinant hepatitis A and B vaccine. While le Halstrom, a GlaxoKline spokeswoman, won't identify the source countries, she said they do not include the United States or Canada. " The entire process was completed more than a year ago ... to ensure we only use materials from countries " with no mad cow infections, Halstrom said. Cow remnants left over from slaughter have long been used to manufacture drugs like vaccines. Serum is drawn from cow's blood and sugars from cow's milk. Amino acids from cow bones are added to growth media to coax along viral vaccines grown in living cells. http://abcnews.go.com/wire/Living/ap20040922_929.html Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 29, 2004 Report Share Posted September 29, 2004 Proposal Aimed at Reducing Mad Cow Risk FDA Proposal Aimed at Reducing Risk of Mad-Cow Tainted Components in Human, Animal Drugs The Associated Press WASHINGTON Sept. 22, 2004 — The government is taking steps to reduce the already minimal risk of mad-cow tainted components ending up in childhood vaccines and other medications. Pharmaceuticals regulated by the Food and Drug Administration, including human vaccines and animal drugs used on farms, routinely use cow products in their manufacture. The agency this summer strengthened safety measures to reduce the chance of mad cow-tainted cow parts winding up in such consumer goods as lipstick and hairspray. One drug company, GlaxoKline, already found alternate sources of materials it uses to produce such products as hepatitis A vaccine and recombinant hepatitis A and B vaccine. While le Halstrom, a GlaxoKline spokeswoman, won't identify the source countries, she said they do not include the United States or Canada. " The entire process was completed more than a year ago ... to ensure we only use materials from countries " with no mad cow infections, Halstrom said. Cow remnants left over from slaughter have long been used to manufacture drugs like vaccines. Serum is drawn from cow's blood and sugars from cow's milk. Amino acids from cow bones are added to growth media to coax along viral vaccines grown in living cells. http://abcnews.go.com/wire/Living/ap20040922_929.html Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 29, 2004 Report Share Posted September 29, 2004 Proposal Aimed at Reducing Mad Cow Risk FDA Proposal Aimed at Reducing Risk of Mad-Cow Tainted Components in Human, Animal Drugs The Associated Press WASHINGTON Sept. 22, 2004 — The government is taking steps to reduce the already minimal risk of mad-cow tainted components ending up in childhood vaccines and other medications. Pharmaceuticals regulated by the Food and Drug Administration, including human vaccines and animal drugs used on farms, routinely use cow products in their manufacture. The agency this summer strengthened safety measures to reduce the chance of mad cow-tainted cow parts winding up in such consumer goods as lipstick and hairspray. One drug company, GlaxoKline, already found alternate sources of materials it uses to produce such products as hepatitis A vaccine and recombinant hepatitis A and B vaccine. While le Halstrom, a GlaxoKline spokeswoman, won't identify the source countries, she said they do not include the United States or Canada. " The entire process was completed more than a year ago ... to ensure we only use materials from countries " with no mad cow infections, Halstrom said. Cow remnants left over from slaughter have long been used to manufacture drugs like vaccines. Serum is drawn from cow's blood and sugars from cow's milk. Amino acids from cow bones are added to growth media to coax along viral vaccines grown in living cells. http://abcnews.go.com/wire/Living/ap20040922_929.html Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.